Home > Boards > US Listed > Biotechs >

Nabriva Therapeutics AG (NBRV)

NBRV RSS Feed 		Add NBRV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/15/2019 11:29:25 AM - Followers: 23 - Board type: Free - Posts Today: 0

Nabriva Therapeutics AG Leberstrasse 20 Vienna, 1110 Austria Phone: 43 1 740 93 0 Fax: 43 1 740 93 1900 Website: http://www.nabriva.com Nabriva Therapeutics AG, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. The company focuses on the pleuromutilin class of antibiotics. Its lead product candidate is lefamulin, which has completed a Phase II clinical trial for acute bacterial skin and skin structure infections. The company is developing intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia; and intends to develop lefamulin for additional indications other than pneumonia. It is also developing BC-7013, a topical pleuromutilin product candidate, which has completed a Phase 1 clinical trial. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics AG in 2007. Nabriva Therapeutics AG was incorporated in 2005 and is headquartered in Vienna, Austria.
NBRV
Current Price
Volume:
Bid Ask Day's Range
NBRV Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NBRV News: Quarterly Report (10-q) 05/10/2019 02:31:53 PM
NBRV News: Current Report Filing (8-k) 05/10/2019 08:31:38 AM
NBRV News: Nabriva Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights 05/10/2019 07:00:00 AM
NBRV News: Nabriva Therapeutics to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference 05/08/2019 04:01:00 PM
NBRV News: Nabriva Therapeutics Announces Submission of Marketing Authorization Application for Lefamulin to Treat Community-Acquired Pn... 05/08/2019 07:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#135   I’m in $272 and waiting. Also in NBRV BUT, net_flyer 05/15/19 11:29:25 AM
#134   Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company realfast95 05/08/19 08:14:48 AM
#133   Anyone notice the nice pop today? Hope this continues. net_flyer 05/06/19 05:45:25 PM
#132   $NBRV upgraded to Hold from Sell at Gabelli. realfast95 05/02/19 06:50:53 PM
#131   * * $NBRV Video Chart 05-01-2019 * * ClayTrader 05/01/19 05:23:09 PM
#130   I think NBRV will adapt and address the PennyWorld 05/01/19 08:55:06 AM
#129   Gabelli's target on the sell was $2.56 realfast95 05/01/19 07:30:21 AM
#128   Lefamulin approval doesnt have a chance if they bUrRpPPP! 05/01/19 07:13:30 AM
#127   yup, facilities are on management. Incompetent is right. realfast95 05/01/19 06:53:43 AM
#126   Contepo is a rebranded name for Fosfomycin...it has bUrRpPPP! 05/01/19 06:42:46 AM
#125   I tried to warn them...eom bUrRpPPP! 05/01/19 06:37:44 AM
#124   [bThe FDA did not request any new clinical DorseyE 05/01/19 12:58:52 AM
#123   Nabriva Therapeutics Receives Complete Response Letter from FDA realfast95 04/30/19 08:43:10 PM
#122   per Burp on twitter realfast95 04/30/19 05:50:21 PM
#121   This sucker tanked, I sold in the AM Mr Fun 04/30/19 05:01:31 PM
#120   Volume through the ROOF we over $3!!! DorseyE 04/30/19 09:52:25 AM
#119   Option Buyers.... DorseyE 04/29/19 02:40:02 PM
#118   Volume picking up! DorseyE 04/29/19 11:13:14 AM
#117   This is still the risk, shot across the realfast95 04/29/19 08:50:28 AM
#116   FDA's decision looming on Nabriva's experimental antibiotic DorseyE 04/29/19 08:42:02 AM
#115   BIG WEEK IS HERE! DorseyE 04/28/19 09:22:59 PM
#114   Try this one... DorseyE 04/23/19 11:40:35 PM
#113   Good links! DorseyE 04/23/19 11:38:01 PM
#112   Per this tweet they have two dates realfast95 04/23/19 01:44:31 PM
#111   better chart realfast95 04/23/19 12:40:04 PM
#110   https://www.biopharmcatalyst.com/calendars/pdufa-calendar jsb330 04/23/19 11:52:06 AM
#109   Jackie Gleason use to say, “HOW SWEET IT IS” DorseyE 04/22/19 11:34:47 AM
#108   scrambled nirvana realfast95 04/22/19 10:40:10 AM
#107   In case anybody noticing our stock trying to DorseyE 04/22/19 09:55:54 AM
#106   My research shows between 8-12.5 DorseyE 04/19/19 01:25:27 PM
#105   Bought more shares @2.69 today! DorseyE 04/18/19 04:58:13 PM
#104   In @2.69 DorseyE 04/12/19 12:05:22 PM
#103   Hummmmmm, thinking about jumping in?? DorseyE 04/06/19 05:14:34 PM
#102   Test realfast95 04/04/19 05:26:24 PM
#101   Gabelli analyst Kevin Kedra downgraded Nabriva Therapeutics AG realfast95 03/27/19 08:46:10 AM
#100   Nabriva Therapeutics Announces Acceptance Of NDA By FDA realfast95 02/19/19 09:19:36 AM
#99   Nabriva Therapeutics Announces Webcast of Analyst & Investor bUrRpPPP! 01/15/19 07:24:18 AM
#98   Sooner is good. Also implies simpler which nsomniyak 01/14/19 06:29:59 PM
#97   NEWS PDUFA ACCELERATED TO APRIL 3OTH!!!! bUrRpPPP! 01/14/19 12:07:51 PM
#96   New Drug Application (NDA) from June 30, 2019 bUrRpPPP! 01/14/19 12:06:49 PM
#95   Here's the best part.......no hiccups..... bUrRpPPP! 01/04/19 07:51:59 AM
#94   U.S. Food and Drug Administration (FDA) has accepted realfast95 01/04/19 07:34:07 AM
#93   ty Message in reply to: [SMART MONEY] 12/28/18 09:46:18 AM
#92   May want to put NBRV back on your bUrRpPPP! 12/28/18 08:16:25 AM
#91   Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical realfast95 12/20/18 07:09:27 AM
#89   Is Lefamulin dead? It would explain why bUrRpPPP! 11/12/18 06:59:33 AM
#88   CONTEPO has been granted Qualified Infectious Disease Product bUrRpPPP! 11/01/18 07:57:21 AM
#87   NBRV $3.10 WEEEEEEEEEEE! bUrRpPPP! 10/04/18 06:16:15 AM
#86   Upgraded by Morgan Stanley today with $8pt. AngryMoose 09/07/18 08:38:43 AM
#85   NBRV chart bUrRpPPP! 09/07/18 08:12:35 AM
PostSubject
© 2019 InvestorsHub.com, Inc.




Ticker News is disabled